We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Hypertension Drugs Market Size: Global Industry and Demand Analysis, Trends, Market Forecast, 2016-2024

Published Date :

2019-06-18

Report Pages :

250

Format :

PDF

Region Covered :

Global

 Global Hypertension Drugs Market 

Market Overview

Many therapeutic agents are utilized for the pharmacologic management of hypertension and the available antihypertensive agents are generally equally effective in lowering blood pressure however; there may be interpatient variability that can affect the way a patient will respond to one treatment over another. 5 mmHg blood pressure declination can reduce the risk of stroke by 34%, ischaemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease.

Goldstein Research analyst forecast the Hypertension Drugs Market size is set to reach USD 33.1 billion by 2024, at a CAGR of 1.12% over the forecast years.

Covered In This Global Hypertension Drugs Market Report

The report covers the present ground scenario and the future growth prospects of the Hypertension Drugs Market for 2016-2024 along with the total number of blood pressure cases worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players and sales of Hypertension Drugs from major players across the globe.

Global Hypertension Drugs - Market Segmentation

By Analysis Basis

  • Systemic Hypertension Drugs
  • Pulmonary Hypertension Drugs

By Therapy Type

  • Calcium Channel Blockers
  • Diuretics
  • Beta Blockers Vasodilators
  • Angiotensin Converting Enzyme Inhibitor
  • Alpha Blockers
  • Angiotensin Receptor Blockers
  • Renin Inhibitors

Based on Geography

  • North America (U.S. & Canada) Hypertension Drugs Market
  • Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Hypertension Drugs Market
  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Hypertension Drugs Market
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Hypertension Drugs Market
  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Hypertension Drugs Market

On the basis of analysis, systemic hypertension drug accounted for 85% of global hypertension drugs market owing to enhanced patient awareness results in an early diagnosis of the disease followed by treatment.

Hypertension Drugs Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Hypertension Drugs market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our global Hypertension Drugs Market report comprises of the following companies as the key players in the Hypertension Drugs Market: Lupin Limited, Novartis AG, Sun Pharmaceuticals LLC, Daiichi - Sankyo, Pfizer Inc., Sanofi S.A, AstraZeneca Plc., Johnson & Johnson Ltd., Boehringer Ingelheim, and Merck & Co, Roche, Abbott, GlaxoSmithKline plc., AstraZeneca, Bayer AG, Gilead, Actelion.

Other high-flying vendors in the market are: Symplmed Pharmaceuticals, Takeda Pharmaceuticals, United Therapeutics, Valeant Pharmaceuticals, XOMA, Yuhan, Ono Pharmaceutical, Northern Therapeutics, Mast Therapeutics, Eiger BioPharmaceuticals.

According to our global market study on the basis of extensive primary and secondary research:  “One trend is changing lifestyle which is responsible to cause disturbance in systolic and diastolic BP and can increase cardiovascular risk that can be measured by non-pharmacological as well as pharmacological means.”

According to the report, major driving factor for expansion of hypertension drugs market is the rising geriatric population. According to WHO, globally, 22% of adults aged over 18yrs had increased blood pressure and USA’s CDC (Centre for Disease control &prevention) articulated that 70 million American adults are suffering from high blood pressure with only approximately 52% i.e. half the patient pool had got the condition under control.

Further, the report states that the major challenge is patent expiry and increase in more market players hinders the market of big pharma giants like patent expiries of drugs such as Micardis, Avapro, and Diovan.

Based on geography, North America dominates the hypertension drugs market with almost 42% market share in 2016 due to the launch of new disease-modifying therapies. The immensely large patient pool in Asia, Europe and Africa is in itself a huge hypertension drugs market driver and hold the opportunities for future relevance.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Hypertension Drugs Market report

  • What is the total market size by 2024 and what would be the expected growth rate of the market?
  • What is the revenue of Hypertension Drugs in 2015-16 and what would be the expected demand over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

 

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report. 




{

Hypertension Drugs Market- Table of Content

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing & Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. Global Economic Overview
2.2. Macroeconomic Outlook
2.3. Demographic Trends Overview
2.4. Global Hypertension Cases Prevalence Analysis
2.5. Global Hypertension Drugs Technology Outlook
2.6. Global Pharmaceutical Industry Outlook
 
3. Industry Structure
3.1. Target Consumer Group Analysis
3.2. Target Markets (By Countries)
3.3. Drugs Research & Development Outlook
3.4. Competitive Strategies
3.5. Acquisitions & Divestitures
3.6. Government Regulatory Framework
 
4. Regional Industry Analysis 
4.1. Manufacturing Outlook
4.2. Revenue Analysis
4.3. Demand & Supply Analysis
4.4. Marketing & Distribution
4.5. Pricing Outlook
4.6. Trade (Import & Export) Analysis
 
5. Executive Summary
5.1. Market Size (USD Million)
5.2. Forecast Analysis (2017-2025)
5.3. Market Share & CAGR (%)
5.4. Regional Share Distribution (%)
 
6. Market Dynamics
6.1. Growth Drivers
6.2. Market Restraints
6.3. Risk Analysis
6.4. Recent Trends & Developments
6.5. Opportunities for Market Players
 
7. Global Hypertension Drugs Market Segmentation
 
7.1. Hypertension Drugs Market By Analysis Basis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.1. Market Share(%) of Hypertension Drugs Market by Analysis Basis
7.1.2. Systemic Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.3. Pulmonary Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.4. Market Attractiveness of Hypertension Drugs Market by Analysis Basis
7.1.5. BPS Analysis of Hypertension Drugs Market by Analysis Basis
 
7.2. Hypertension Drugs Market ByTherapy Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.1. Market Share(%) of Hypertension DrugsMarket by Therapy Type
7.2.2. Calcium Channel Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.3. Diuretics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.4. Beta Blockers Vasodilators (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.5. Angiotensin Converting Enzyme Inhibitor (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.6. Alpha Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.7. Angiotensin Receptor Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.8. Renin Inhibitors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.9. Market Attractiveness of Hypertension DrugsMarket by Therapy Type
7.2.10. BPS Analysis of Hypertension DrugsMarket by Therapy Type
 
7.3. Hypertension DrugsMarket By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
 
7.3.1. North America Hypertension Drugs Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
7.3.1.1. North America Hypertension Drugs Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.3.1.1.1. U.S. Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.1.2. Canada Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.1.3. Market Attractiveness of Hypertension DrugsMarket by Country
7.3.1.1.4. BPS Analysis of Hypertension DrugsMarket by Country
 
7.3.1.2. North America Hypertension Drugs Market By Analysis Basis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.2.1. Market Share(%) of Hypertension Drugs Market by Type
7.3.1.2.2. Systemic Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.2.3. Pulmonary Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.2.4. Market Attractiveness of Hypertension Drugs Market by Analysis Basis
7.3.1.2.5. BPS Analysis of Hypertension Drugs Market by Analysis Basis
 
7.3.1.3. North America Hypertension Drugs Market By Therapy Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.1. Market Share(%) of Hypertension Drugs Market by Therapy Type
7.3.1.3.2. Calcium Channel Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.3. Diuretics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.4. Beta Blockers Vasodilators (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.5. Angiotensin Converting Enzyme Inhibitor (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.6. Alpha Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.7. Angiotensin Receptor Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.8. Renin Inhibitors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1.3.9. Market Attractiveness of Hypertension Drugs Market by Therapy Type
7.3.1.3.10. BPS Analysis of Hypertension Drugs Market by Therapy Type
 
7.3.2. Europe Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
7.3.2.1. Europe Hypertension Drugs MarketBy Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.3.2.1.1. UK Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.2. France Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.3. Italy Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.4. Germany Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.5. Spain Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.6. Hungary Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.7. Sweden Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.8. Russia Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.9. Poland Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.10. Rest of EuropeHypertension Drugs Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.1.11. Market Attractiveness of Hypertension DrugsMarket by Country
7.3.2.1.12. BPS Analysis of Hypertension DrugsMarket by Country
 
7.3.2.2. Europe Hypertension Drugs Market By Analysis Basis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.2.1. Market Share(%) of Hypertension Drugs Market by Type
7.3.2.2.2. Systemic Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.2.3. Pulmonary Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.2.4. Market Attractiveness of Hypertension Drugs Market by Analysis Basis
7.3.2.2.5. BPS Analysis of Hypertension Drugs Market by Analysis Basis
 
7.3.2.3. Europe Hypertension Drugs Market By Therapy Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.1. Market Share(%) of Hypertension Drugs Market by Therapy Type
7.3.2.3.2. Calcium Channel Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.3. Diuretics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.4. Beta Blockers Vasodilators (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.5. Angiotensin Converting Enzyme Inhibitor (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.6. Alpha Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.7. Angiotensin Receptor Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.8. Renin Inhibitors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.2.3.9. Market Attractiveness of Hypertension Drugs Market by Therapy Type
7.3.2.3.10. BPS Analysis of Hypertension Drugs Market by Therapy Type
 
7.3.3. Middle East & Africa Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
7.3.3.1. Middle East & Africa Hypertension DrugsMarket By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.3.3.1.1. Gulf Cooperation Council Countries (GCC) Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.1.2. South Africa Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.1.3. North Africa Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.1.4. Rest of Middle East and Africa Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.1.5. Market Attractiveness of Hypertension DrugsMarket by Country 
7.3.3.1.6. BPS Analysis of Hypertension DrugsMarket by Country
 
7.3.3.2. Middle East & Africa Hypertension Drugs Market By Analysis Basis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.2.1. Market Share(%) of Hypertension Drugs Market by Type
7.3.3.2.2. Systemic Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.2.3. Pulmonary Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.2.4. Market Attractiveness of Hypertension Drugs Market by Analysis Basis
7.3.3.2.5. BPS Analysis of Hypertension Drugs Market by Analysis Basis
 
7.3.3.3. Middle East & Africa Hypertension Drugs Market By Therapy Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.1. Market Share(%) of Hypertension Drugs Market by Therapy Type
7.3.3.3.2. Calcium Channel Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.3. Diuretics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.4. Beta Blockers Vasodilators (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.5. Angiotensin Converting Enzyme Inhibitor (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.6. Alpha Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.7. Angiotensin Receptor Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.8. Renin Inhibitors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3.3.9. Market Attractiveness of Hypertension Drugs Market by Therapy Type
7.3.3.3.10. BPS Analysis of Hypertension Drugs Market by Therapy Type
 
7.3.4. Latin America Hypertension Drugs Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
7.3.4.1. Latin America Hypertension DrugsBy Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.3.4.1.1. Brazil Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.1.2. Mexico Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.1.3. Rest of Latin America Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.1.4. Market Attractiveness of Hypertension DrugsMarket by Country 
7.3.4.1.5. BPS Analysis of Hypertension DrugsMarket by Country
 
7.3.4.2. Latin America Hypertension Drugs Market By Analysis Basis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.2.1. Market Share(%) of Hypertension Drugs Market by Type
7.3.4.2.2. Systemic Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.2.3. Pulmonary Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.2.4. Market Attractiveness of Hypertension Drugs Market by Analysis Basis
7.3.4.2.5. BPS Analysis of Hypertension Drugs Market by Analysis Basis
 
7.3.4.3. Latin America Hypertension Drugs Market By Therapy Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.1. Market Share(%) of Hypertension Drugs Market by Therapy Type
7.3.4.3.2. Calcium Channel Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.3. Diuretics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.4. Beta Blockers Vasodilators (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.5. Angiotensin Converting Enzyme Inhibitor (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.6. Alpha Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.7. Angiotensin Receptor Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.8. Renin Inhibitors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4.3.9. Market Attractiveness of Hypertension Drugs Market by Therapy Type
7.3.4.3.10. BPS Analysis of Hypertension Drugs Market by Therapy Type
 
7.3.5. Asia Pacific (APAC) Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
7.3.5.1. Asia Pacific Hypertension DrugsMarket By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.3.5.1.1. China Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.2. Japan Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.3. India Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.4. Singapore Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.5. South Korea Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.6. Australia Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.7. New Zealand Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.8. Rest of APAC Hypertension DrugsMarket (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.1.9. Market Attractiveness of Hypertension DrugsMarket by Country 
7.3.5.1.10. BPS Analysis of Hypertension DrugsMarket by Country
 
7.3.5.2. Asia Pacific Hypertension Drugs Market By Analysis Basis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.2.1. Market Share(%) of Hypertension Drugs Market by Type
7.3.5.2.2. Systemic Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.2.3. Pulmonary Hypertension Drugs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.2.4. Market Attractiveness of Hypertension Drugs Market by Analysis Basis
7.3.5.2.5. BPS Analysis of Hypertension Drugs Market by Analysis Basis
 
7.3.5.3. Asia Pacific Hypertension Drugs Market By Therapy Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.1. Market Share(%) of Hypertension Drugs Market by Therapy Type
7.3.5.3.2. Calcium Channel Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.3. Diuretics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.4. Beta Blockers Vasodilators (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.5. Angiotensin Converting Enzyme Inhibitor (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.6. Alpha Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.7. Angiotensin Receptor Blockers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.8. Renin Inhibitors (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5.3.9. Market Attractiveness of Hypertension Drugs Market by Therapy Type
7.3.5.3.10. BPS Analysis of Hypertension Drugs Market by Therapy Type
 
8. Competitive Outlook
8.1. Market Share of Major Players 
8.2. Company Profiles
8.2.1. Novartis AG
8.2.1.1. Company Synopsis
8.2.1.2. Business Strategy
8.2.1.3. Product Portfolio
8.2.1.4. SWOT Analysis
8.2.2. Lupin Limited
8.2.3. Sun Pharmaceuticals LLC
8.2.4. Daiichi – Sankyo
8.2.5. Pfizer Inc.
8.2.6. Sanofi S.A
8.2.7. AstraZeneca Plc.
8.2.8. Johnson & Johnson Ltd.
8.2.9. BoehringerIngelheim
8.2.10. Merck & Co
8.2.11. Roche
8.2.12. Abbott
8.2.13. GlaxoSmithKline plc.
8.2.14. AstraZeneca
8.2.15. Bayer AG
8.2.16. Gilead
8.2.17. Actelion
 
9. Porter’s Five Force Model
10. Market Landscape: Competition and Beyond
11. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
12. Expert Analysis
13. Concluding Remarks
}

Hypertension Drugs Market Size: Global Industry and Demand Analysis, Trends, Market Forecast, 2016-2024

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

BROWSE SIMILAR REPORTS

Please Select Linenece Type